Literature DB >> 11384698

Excessive uterine activity accompanying induced labor.

J M Crane1, D C Young, K D Butt, K A Bennett, D Hutchens.   

Abstract

OBJECTIVE: To estimate the incidence and timing of excessive uterine activity accompanying induction of labor with misoprostol using different routes (oral or vaginal) and forms (intact tablet or crushed) and to compare these with dinoprostone gel, oxytocin, and spontaneous labor.
METHODS: This retrospective cohort study included 519 women at term who had labor induced and 86 women at term in spontaneous labor. Induction agents included misoprostol, dinoprostone, or oxytocin. Fetal heart rate and uterine activity tracings were analyzed independently by three maternal-fetal medicine physicians. The diagnosis of tachysystole or hyperstimulation required the agreement of two or more reviewers.
RESULTS: The incidence of tachysystole was highest with misoprostol administered by vaginal tablet (misoprostol vaginal tablet 50 microg every 4 hours, 48.6%; vaginal tablet crushed 50 microg and suspended in hydroxyethyl gel every 4 hours, 30.7%, P =.009; oral tablet 50 microg every 4 hours, 22.2%, P =.001; oral tablet crushed 50 microg every 4 hours, 15.5%, P <.001; dinoprostone gel, 33.0%, P =.022; intravenous oxytocin, 30.2%, P =.027; and spontaneous onset of labor, 23.3%, P <.001). Hyperstimulation occurred more often with dinoprostone gel (16.5%) than with other forms of induction or spontaneous labor. Hyperstimulation occurred significantly more often with vaginal misoprostol crushed tablet (7.9%) and vaginal misoprostol intact tablet (7.6%) than with crushed oral misoprostol (1.0%) (P =.016 and.018, respectively). There was a shorter time to tachysystole with increasing doses of vaginal misoprostol tablet (P =.01).
CONCLUSION: The incidence of tachysystole and hyperstimulation, and time to tachysystole, varied depending on the route and form of misoprostol given.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384698     DOI: 10.1016/s0029-7844(01)01332-1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  In utero exposure to transient ischemia-hypoxemia promotes long-term neurodevelopmental abnormalities in male rat offspring.

Authors:  Arvind Palanisamy; Tusar Giri; Jia Jiang; Annie Bice; James D Quirk; Sara B Conyers; Susan E Maloney; Nandini Raghuraman; Adam Q Bauer; Joel R Garbow; David F Wozniak
Journal:  JCI Insight       Date:  2020-05-21

2.  Maternal intravaginal prostaglandin E2 gel before elective caesarean section at term to induce catecholamine surge in cord blood: randomised, placebo controlled study.

Authors:  M Singh; S Patole; A Rane; D Naidoo; P Buettner
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

Review 3.  Acute tocolysis for uterine tachysystole or suspected fetal distress.

Authors:  Sebastian J Leathersich; Joshua P Vogel; Thach Son Tran; G Justus Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2018-07-04

4.  Sublingual versus Vaginal Misoprostol for the Induction of Labor at Term: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.

Authors:  Bahia Namavar Jahromi; Foroogh Poorgholam; Gholamhossein Yousefi; Leila Salarian
Journal:  Iran J Med Sci       Date:  2016-03

5.  Labor induction with oxytocin in pregnant rats is not associated with oxidative stress in the fetal brain.

Authors:  Tusar Giri; Jia Jiang; Zhiqiang Xu; Ronald McCarthy; Carmen M Halabi; Eric Tycksen; Alison G Cahill; Sarah K England; Arvind Palanisamy
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

6.  Reducing neonatal morbidity by discontinuing oxytocin during the active phase of first stage of labor: a multicenter randomized controlled trial STOPOXY.

Authors:  Aude Girault; François Goffinet; Camille Le Ray
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-20       Impact factor: 3.007

7.  Intrapartum uterine activity and neonatal outcomes: a systematic review.

Authors:  Adam J Reynolds; Michael P Geary; Breda C Hayes
Journal:  BMC Pregnancy Childbirth       Date:  2020-09-12       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.